Substance / Medication

Caspofungin

Overview

Active Ingredient
caspofungin
RxNorm CUI
140108

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

8 trials linked to this intervention

8
Total Trials
1
Recruiting
3
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Rezafungin vs caspofungin for the treatment of invasive candidiasis: A systematic review and meta-analysis.
Al Diab Al Azzawi Mohammad, Abdat Wejdan, Alhamed Arina et al. · Diagn Microbiol Infect Dis · 2025
PMID: 40651396Meta-Analysis
Efficacy and safety of caspofungin in children: systematic review and meta-analysis.
Rosanova María T, Bes David, Serrano Aguilar Pedro et al. · Arch Argent Pediatr · 2016
PMID: 27399007Meta-Analysis
Caspofungin versus liposomal amphotericin B for treatment of invasive fungal infections or febrile neutropenia.
Zhang Jinyu, Gong Yizhen, Wang Ke et al. · Chin Med J (Engl) · 2014
PMID: 24534235Meta-Analysis
Caspofungin for the treatment of fungal infections: a systematic review of randomized controlled trials.
Falagas Matthew E, Ntziora Fotinie, Betsi Gregoria I et al. · Int J Antimicrob Agents · 2007
PMID: 17207609Meta-Analysis
Comparative efficacy and safety of topical caspofungin 0.5% and voriconazole 1% for fungal keratitis: a pilot clinical trial.
Atighehchian Mehrnaz, Latifi Golshan, Bardan Ahmed Shalaby et al. · Sci Rep · 2025
PMID: 41198723RCTFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Caspofungin (substance)
SNOMED CT
413770001
UMLS CUI
C0537894
RxNorm CUI
140108

Clinical Data

This intervention maps to 3 entities in the Ltrl knowledge graph.

3
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
8
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.